(Q84405768)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20548314%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

From cell signaling to novel therapeutic concepts: international pemphigus meeting on advances in pemphigus research and therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20548314%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

2

Jens Waschke

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20548314%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Spiro Getsios

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20548314%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Luca Borradori

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20548314%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Michael Hertl

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20548314%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Eliane J Müller

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20548314%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

language of work or name

English

0 references

publication date

1 July 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20548314%20AND%20SRC:MED&resulttype=core&format=json

Journal of Investigative Dermatology

5 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20548314%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

130

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20548314%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20548314%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

1764-1768

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20548314%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/jid.2010.111

5 February 2020

exact match

0 references

cites work

ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.111

7 January 2021

A randomized double-blind trial of intravenous immunoglobulin for pemphigus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.111

7 January 2021

Tolerance induction by the blockade of CD40/CD154 interaction in pemphigus vulgaris mouse model

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.111

7 January 2021

Mechanisms of action of therapeutics in idiopathic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.111

7 January 2021

New approaches of B-cell-directed therapy: beyond rituximab

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.111

7 January 2021

Rituximab exerts a dual effect in pemphigus vulgaris

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.111

7 January 2021

Desmoglein 1-dependent suppression of EGFR signaling promotes epidermal differentiation and morphogenesis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.111

7 January 2021

T cell control in autoimmune bullous skin disorders

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.111

7 January 2021

A single cycle of rituximab for the treatment of severe pemphigus.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.111

7 January 2021

Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.111

7 January 2021

B-cell-directed therapy for inflammatory skin diseases

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.111

7 January 2021

Clinical and immunological follow-up of pemphigus patients on adjuvant treatment with immunoadsorption or rituximab

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.111

7 January 2021

Reliability and convergent validity of two outcome instruments for pemphigus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.111

7 January 2021

Treatment of severe pemphigus with protein A immunoadsorption, rituximab and intravenous immunoglobulins

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.111

7 January 2021

Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.111

7 January 2021